IL215770A0 - Replikin-sequences for preventing/treating influenza and determining infectivity/ lethality - Google Patents

Replikin-sequences for preventing/treating influenza and determining infectivity/ lethality

Info

Publication number
IL215770A0
IL215770A0 IL215770A IL21577011A IL215770A0 IL 215770 A0 IL215770 A0 IL 215770A0 IL 215770 A IL215770 A IL 215770A IL 21577011 A IL21577011 A IL 21577011A IL 215770 A0 IL215770 A0 IL 215770A0
Authority
IL
Israel
Prior art keywords
replikin
lethality
sequences
preventing
treating influenza
Prior art date
Application number
IL215770A
Original Assignee
Bogoch Samuel
Elenore S Bogoch
Samuel Winston Bogoch
Anne Elenore Borsanyi
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US12/429,044 external-priority patent/US20090269367A1/en
Priority claimed from PCT/US2009/041565 external-priority patent/WO2009132209A2/en
Priority claimed from US12/538,027 external-priority patent/US20100144589A1/en
Application filed by Bogoch Samuel, Elenore S Bogoch, Samuel Winston Bogoch, Anne Elenore Borsanyi filed Critical Bogoch Samuel
Publication of IL215770A0 publication Critical patent/IL215770A0/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/145—Orthomyxoviridae, e.g. influenza virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/10—Peptides having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/162—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
    • G01N2333/08—RNA viruses
    • G01N2333/11—Orthomyxoviridae, e.g. influenza virus
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/32—Cardiovascular disorders
    • G01N2800/325—Heart failure or cardiac arrest, e.g. cardiomyopathy, congestive heart failure

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Mycology (AREA)
  • Pulmonology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Physics & Mathematics (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cell Biology (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Oncology (AREA)
  • Analytical Chemistry (AREA)
IL215770A 2009-04-23 2011-10-23 Replikin-sequences for preventing/treating influenza and determining infectivity/ lethality IL215770A0 (en)

Applications Claiming Priority (8)

Application Number Priority Date Filing Date Title
US17211509P 2009-04-23 2009-04-23
US12/429,044 US20090269367A1 (en) 2008-04-23 2009-04-23 Methods and compounds for mitigating pathogenic outbreaks using replikin count cycles
PCT/US2009/041565 WO2009132209A2 (en) 2008-04-23 2009-04-23 Methods and compounds for mitigating pathogenic outbreaks using replikin count cycles
US17968609P 2009-05-19 2009-05-19
US18516009P 2009-06-08 2009-06-08
US12/538,027 US20100144589A1 (en) 2008-08-08 2009-08-07 Methods of predicting cancer lethality using replikin counts
US24600609P 2009-09-25 2009-09-25
PCT/US2009/061108 WO2010123519A1 (en) 2009-04-23 2009-10-16 Replikin-sequences for preventing/treating influenza and determining infectivity/lethality

Publications (1)

Publication Number Publication Date
IL215770A0 true IL215770A0 (en) 2012-01-31

Family

ID=41528810

Family Applications (1)

Application Number Title Priority Date Filing Date
IL215770A IL215770A0 (en) 2009-04-23 2011-10-23 Replikin-sequences for preventing/treating influenza and determining infectivity/ lethality

Country Status (7)

Country Link
EP (1) EP2421546A1 (en)
AU (1) AU2009344843A1 (en)
CA (1) CA2759325A1 (en)
IL (1) IL215770A0 (en)
NZ (1) NZ595812A (en)
SG (2) SG175275A1 (en)
WO (1) WO2010123519A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9320784B2 (en) 2009-08-07 2016-04-26 Samuel Bogoch Peptides shared among lethal cancers and therapeutic compositions comprising said peptides
WO2013151662A2 (en) 2012-03-09 2013-10-10 Samuel Bogoch Therapies, vaccines, and predictive methods for infectious salmon anemia virus
WO2014165274A2 (en) * 2013-03-13 2014-10-09 Samuel Bogoch Methods of diagnosing, preventing, and treating drug-resistant pathogenic infections using replikin sequences
CN110680912B (en) * 2019-09-26 2021-08-17 中国农业大学 H3N2 and H3N8 subtype canine influenza bivalent inactivated vaccine as well as preparation method and application thereof

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7189800B2 (en) * 2001-03-27 2007-03-13 Samuel Bogoch Replikin peptides in rapid replication of glioma cells and in influenza epidemics
CA2598381A1 (en) * 2005-02-16 2006-08-24 Samuel Bogoch Replikin peptides and uses thereof
EP1924282B1 (en) * 2005-08-15 2017-01-11 Altimmune Inc. Immunization of avians by administration of non-replicating vectored vaccines
JP2009535306A (en) * 2006-04-21 2009-10-01 ダウ・アグロサイエンス・エル・エル・シー Vaccines against bird flu and methods of use
CA2654178A1 (en) * 2006-06-16 2007-12-27 Dow Agrosciences Llc Novel dna sequences, vectors and proteins of avian influenza hemagglutinin
CA2660038A1 (en) * 2006-08-14 2008-06-19 Massachusetts Institute Of Technology Hemagglutinin polypeptides, and reagents and methods relating thereto
US20080241188A1 (en) * 2007-03-30 2008-10-02 Zeon Corporation Turkey herpesvirus vectored recombinant containing avian influenza genes

Also Published As

Publication number Publication date
EP2421546A1 (en) 2012-02-29
SG175275A1 (en) 2011-11-28
AU2009344843A1 (en) 2011-11-10
WO2010123519A1 (en) 2010-10-28
SG10201401532PA (en) 2014-08-28
NZ595812A (en) 2013-09-27
CA2759325A1 (en) 2010-10-28

Similar Documents

Publication Publication Date Title
HK1255283A1 (en) Compounds and methods for treating influenza
IL262734B (en) Influenza virus inhibitor compounds and uses thereof
HK1214514A1 (en) Neuroinvasion inhibitor
AP3409A (en) Inhibitors of flaviviridae viruses
ZA201109352B (en) Germicidal fixture and methods
EP2484368A4 (en) Virus inactivation sheet
ZA201109319B (en) Chemical modification motifs for mirna inhibitors and mimetics
BRPI0924512A2 (en) secure application execution delivery method and appliance
HK1170740A1 (en) Inhibitors of flaviviridae viruses
IL210097B (en) Compositions and methods for treating influenza
EP2497482A4 (en) Composition for preventing and treating influenza-virus-induced diseases
BRPI1013338A2 (en) processes and intermediaries
EP2504428A4 (en) Methods and compositions for treating oxalate-related conditions
BR112012010242A2 (en) heteroarylpiperidine and heteroarylpiperazine derivatives
BRPI0811870A2 (en) INFLUENCE TREATMENT AND PREVENTION
EP2448596A4 (en) Compositions and methods for diagnosing and/or treating influenza infection
BRPI0910474A2 (en) casting machine and casting machine valve
GB2469117B (en) Identifying malware
EP2262958A4 (en) Drain and inlet member for drain
BRPI1014442A2 (en) dispenser and method
IL215770A0 (en) Replikin-sequences for preventing/treating influenza and determining infectivity/ lethality
GB0912950D0 (en) Virus
GB0901056D0 (en) Virus
FIU20090441U0 (en) UVC treated paper
GB0921333D0 (en) Sterilizer